Skip to Content

PhD Public Seminar: SIYUAN HE, MS

When & Where

June 11
3:00 PM - 4:00 PM
UTHH – MD Anderson Cancer Center, Z10.1003ab (Zayed Building, 10th Floor) and via Zoom (View in Google Map)

Contact

Event Description

Decoding Breast Cancer Development Through Single Cell and Spatial Genomics 

Siyuan He, MS (Advisor: Nicholas Navin, PhD) 

          Ductal carcinoma in situ (DCIS) is a preinvasive breast cancer in which cancer cells remain confined within the lumen of ducts. With the adoption of mammography, DCIS diagnoses have risen significantly, with approximately 50,000 new cases each year in the U.S. While 10-30% of DCIS patients progress to invasive disease (IDC) within the next 10 years, the lack of reliable biomarkers to predict DCIS recurrence leads to overtreatment, with almost all patients undergoing aggressive surgery, radiotherapy and chemotherapy. To better understand DCIS initiation and progression, we performed single-cell and spatial profiling of DCIS and IDC tissues. To overcome key limitations in spatial analysis, we first developed a computational tool, CellTrek, that directly maps single cells onto tissue sections. Applying CellTrek to DCIS samples, we found distinct cancer subclonal spatial architectures and immune cell distribution. Next, to establish a baseline for comparison, we constructed a human breast cell atlas from normal breast tissues, identifying 12 major cell types and 58 cell states with distinct spatial organization. Building on these foundational resources, we uncovered reprogrammed basal cells, vascular cells and fibroblasts that encircled the DCIS lesions. Notably, only lipo-macrophages and interferon T cells infiltrated DCIS regions, as well as the formation of tertiary lymphoid structures adjacent to lesions. Furthermore, DCIS cancer cells showed upregulated cell cycling and interferon signaling programs, while reducing cell adhesion, RNA processing, cell growth regulation and secretion pathways. Together, our data highlight extensive microenvironmental remodeling in DCIS that persists in invasive progression, providing new insights for risk stratification and targeted therapy development.

Advisory Committee:

  • Nicholas Navin, PhD, Chair
  • Ann Killary, PhD
  • Savitri Krishnamurthy, MD
  • Alastair Thompson, MD
  • Linghua Wang, PhD
  • Wenyi Wang, PhD

Join via Zoom (Please contact Mr. Siyuan He for the details of his Zoom meeting info)

{ "name":"PhD Public Seminar: SIYUAN HE, MS", "description":"

Decoding Breast Cancer Development Through Single Cell and Spatial Genomics 

Siyuan He, MS (Advisor: Nicholas Navin, PhD) 

          Ductal carcinoma in situ (DCIS) is a preinvasive breast cancer in which cancer cells remain confined within the lumen of ducts. With the adoption of mammography, DCIS diagnoses have risen significantly, with approximately 50,000 new cases each year in the U.S. While 10-30% of DCIS patients progress to invasive disease (IDC) within the next 10 years, the lack of reliable biomarkers to predict DCIS recurrence leads to overtreatment, with almost all patients undergoing aggressive surgery, radiotherapy and chemotherapy. To better understand DCIS initiation and progression, we performed single-cell and spatial profiling of DCIS and IDC tissues. To overcome key limitations in spatial analysis, we first developed a computational tool, CellTrek, that directly maps single cells onto tissue sections. Applying CellTrek to DCIS samples, we found distinct cancer subclonal spatial architectures and immune cell distribution. Next, to establish a baseline for comparison, we constructed a human breast cell atlas from normal breast tissues, identifying 12 major cell types and 58 cell states with distinct spatial organization. Building on these foundational resources, we uncovered reprogrammed basal cells, vascular cells and fibroblasts that encircled the DCIS lesions. Notably, only lipo-macrophages and interferon T cells infiltrated DCIS regions, as well as the formation of tertiary lymphoid structures adjacent to lesions. Furthermore, DCIS cancer cells showed upregulated cell cycling and interferon signaling programs, while reducing cell adhesion, RNA processing, cell growth regulation and secretion pathways. Together, our data highlight extensive microenvironmental remodeling in DCIS that persists in invasive progression, providing new insights for risk stratification and targeted therapy development.

Advisory Committee:

  • Nicholas Navin, PhD, Chair
  • Ann Killary, PhD
  • Savitri Krishnamurthy, MD
  • Alastair Thompson, MD
  • Linghua Wang, PhD
  • Wenyi Wang, PhD

Join via Zoom (Please contact Mr. Siyuan He for the details of his Zoom meeting info)

", "startDate":"2025-6-11", "endDate":"2025-6-11", "startTime":"15:00", "endTime":"16:00", "location":"UTHH – MD Anderson Cancer Center, Z10.1003ab (Zayed Building, 10th Floor) and via Zoom", "label":"Add to Calendar", "options":[ "Apple", "Google", "iCal", "Microsoft365", "MicrosoftTeams", "Yahoo" ], "timeZone":"America/Chicago", "trigger":"click", "inline":true, "listStyle":"modal", "iCalFileName":"Reminder-Event" }